“Long-Term Efficacy of Omalizumab in Patients With Conventional Treatment-Resistant Vernal Keratoconjunctivitis”. Revista Alergia México, vol. 65, no. 2, July 2018, pp. 192-6, https://doi.org/10.29262/ram.v65i2.292.